Spontaneous blink rates correlate with dopamine levels in the caudate nucleus of MPTP-treated monkeys

Experimental Neurology

Volumn 158, Issue 1, 1999, Pages 214-220

  Taylor, J R ^a   Elsworth, J D ^a   Lawrence, M S ^a   Sladek Jr , J R ^b   Roth, R H ^a   Redmond Jr , D E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b The Chicago Medical College   (United States)

Author keywords

Blink rate; MPTP; Parkinson's disease dopamine

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; DIHYDREXIDINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 1 RECEPTOR STIMULATING AGENT; DOPAMINE 2 RECEPTOR; DOPAMINE 2 RECEPTOR STIMULATING AGENT; HOMOVANILLIC ACID; NEUROTOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CAUDATE NUCLEUS; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; EYELID REFLEX; MALE; MONKEY; NONHUMAN; PARKINSONISM; PRIORITY JOURNAL;

EID: 0032818081     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1999.7093     Document Type: Article

References (52)

1. Karsen C. N. Spontaneous eye-blink rates and dopaminegic systems. Brain. 106:1983;643-653.
2. Karsen C., Staub R. A., Kleinman J. E., Wyatt R. J. Drug effects in rhesus monkeys: Preliminary studies. Biol. Psychiatry. 16:1981;249-254.
3. Karsen C. N., Dykman R. A., Paige S. R. Blink rates in schizophrenia. Schizophr. Bull. 16:1990;345-354.
4. Hall A. The origin and purpose of blinking. Br. J. Ophthalmol. 29:1945;445-467.
5. Stevens J. R. Eye blink rate and schizophrenia: Psychosis or tardive dyskinesia. Am. J. Psychiatry. 135:1978;224-226.
6. Karsen C. N., Freed W. J., Kleinman J. E., Bigelow L. B., Wyatt R. J. Neuroleptics decrease blinking in schizophrenic subjects. Biol. Psychiatry. 16:1981;679-682.
7. Karsen C. N., Burns R., LeWitt P. A., Foster N. L., Newman R. P. Blink rates and disorders of movement. Neurology. 34:1984;677-678.
8. Karsen C. N., Kaufman C. A., Shapiro A. K., Shapiro E. Eye-blink rates in Tourette's syndrome. J. Nervous Mental Dis. 173:1985;566-569.
9. Karsen C. N., LeWitt P. A., Calne D. B., Wyatt R. J. Blink rates in parkinsonism. Ann. Neurol. 12:1982;580-583.
10. Lawrence M. S., Redmond D. E. Jr. MPTP lesions and dopaminergic drugs alter eye blink rate in African green monkeys. Pharmacol. Biochem. Behav. 38:1991;869-874.
11. Hantraye P., Varaset M., Peschanski M., Riche D., Cesaro P., Willer J. C., Maziere M. Stable parkinsonism syndrome and uneven loss of striatal dopamine fibers following chronic MPTP administration in baboons. Neuroscience. 53:1993;169-178.
12. Brewster W. K., Nichols D. E., Riggs R. M., Mottola D. M., Lovenberg T. W., Lewis M. H., Mailman R. M. trans-10,11-Dihydroxy-5,6,6a,7,8,12b-hexahydrobenzo[a] phenanthridine: A highly potent selective dopamine D1 full agonist. J. Med. Chem. 33:1990;1756.
13. 1 agonist, reduces MPTP-induced parkinsonism in African green monkeys. Eur. J. Pharmacol. 199:1991;387-388.
14. Lawrence M. S., Redmond D. E. Jr., Elsworth J. D., Taylor J. R., Roth R. H. The D1 receptor antagonist, SCH23390, induces signs of parkinsonism in African green monkeys. Life Sci. Pharmacol. Lett. 49:1991;PL229-PL234.
15. Elsworth J. D., Lawrence M. S., Roth R. H., Taylor J. R., Mailman R. B., Nichols D. E., Lewis M. H., Redmond D. E. Jr. D1 and D2 dopamine receptors independently regulate spontaneous blink rate in the vervet monkey. J. Pharmacol. Exp. Ther. 259:1991;595-600.
16. Karsen C., Staub R. A., Kleinman J. E., Wyatt R. J. Drug effects in rhesus monkeys: Preliminary studies. Biol. Psychiatry. 16:1981;249-254.
17. Guide for the Care and Use of Animals. 1985;U.S. Govt. Printing Office, Washington.
18. Taylor J. R., Elsworth J. D., Roth R. H., Sladek J. R. Jr., Redmond D. E. Jr. Behavioral effects of MPTP administration in the vervet monkey: a primate model of Parkinson's disease. Woodruff M. L., Nonneman A. J. Toxin-Induced Models of Neurological Disorders. 1994;139-174 Plenum, New York.
19. Taylor J. R., Elsworth J. D., Roth R. H., Sladek J. R. Jr., Redmond D. E. Jr. Severe long-term MPTP-induced parkinsonismin the vervet monkey (Cercopithecus aethiops sabaeus). Neuroscience. 81:1997;745-755.
20. Redmond D. E. Jr., Sladek J. R. Jr., Roth R. H., Collier T. J., Elsworth J. D., Deutch A. Y., Haber S. N. Fetal neuronal grafts in monkeys given methylphenyltetrahydropyridine. Lancet. 8490:1986;1125-1127.
21. Sladek J. R. Jr., Elsworth J. D., Taylor J. R., Roth R. H., Redmond D. E. Jr. Techniques for neural transplantation in non-human primates. Ricordi C., Landes R. G. Methods in Cell Transplantation. 1994;391-408 CRC Press, Austin.
22. Sladek J. R. Jr., Blanchard B., Collier T. J., Elsworth J. D., Taylor J. R., Roth R. H., Redmond D. E. Jr. Development of mesencephalic dopamine neurons in the non-human primate relationship to survival and growth. Bloom F. E., Kupfer D. J. Psychopharmacology: The Fourth Generation of Progress. 1995;269-282 Raven Press, New York.
23. Elsworth J. D., Deutch A. Y., Redmond D. E. Jr., Sladek J. R. Jr., Roth R. H. Effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) on catecholamines and metabolites in primate brain and CSF. Brain Res. 415:1987;293-299.
24. Elsworth J. D., Deutch A. Y., Redmond D. E. Jr., Taylor J. R., Sladek J. R. Jr., Roth R. H. Symptomatic and asymptomatic 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated primates: Biochemical changes in striatal regions. Neuroscience. 33:1989;323-331.
25. 1 agonist, reduces MPTP-induced parkinsonism in the African green monkey. Neurosci. Abstr. 17:1991;1075.
26. Hikosaka O. The role of the basal ganglia in saccades. Rev. Neurol. (Paris). 145:1989;580-596.
27. Evinger C., Manning C. A., Sibony P. A. Eyelid movements: Mechanisms and normal data. Invest. Ophthalmol. Vis. Sci. 32:1991;387-400.
28. Evinger C., Manning C. A., Pellegrini J. J., Basso M. A., Powers A. S., Sibony P. A. Not looking while leaping: The linkage of blinking and saccadic gaze shifts. Exp. Brain Res. 100:1994;337-344.
29. Watanabe Y., Fujita T., Gyoba J. Investigation of the blinking dependent on saccadic eye movement. Tohoku Psychol. Folia. 39:1980;121-129.
30. Zee D. S., Chu F. C., Leigh R. J., Savino P. J., Schatz N. J., Reingold D. B., Cogan D. Blink-saccade synkenesis. Neurology. 33:1983;1233-1236.
31. Shibasaki H., Tsuji S., Koroiwa Y. Oculomotor abnormalities in Parkinson's disease. Arch. Neurol. 36:1979;360-364.
32. Rascol O., Clanet M., Montastruc J. L. Abnormal ocular movements in Parkinson's disease. Brain. 112:1989;1193-1214.
33. Warabi T., Noda H., Yanagisawa N., Tashiro K., Shindo R. Changes in sensorimotor function associated with the degree of bradykinesia of Parkinson's disease. Brain. 109:1986;1209-1224.
34. White O. B., Saint-Cyr J. A., Tomlinson R. D., Sharpe J. A. Ocular motor deficits in Parkinson's disease. II. Control of the saccadic and smooth pursuit systems. Brain. 106:1983;571-587.
35. Kitagawa M., Fukushima J., Tashiro K. Relationship between antisaccades and the clinical symptoms in Parkinson's disease. Neurology. 44:1994;2285-2289.
36. Alexander G. E., DeLong M. R., Strick P. L. Parallel organization of functionally segregated circuits linking basal ganglia and cortex. Annu. Rev. Neurosci. 9:1986;357-381.
37. DeLong M. R., Alexander G. E., Miller W. C., Crutcher M. D. Anatomical and functional aspects of basal ganglia-thalamocortical circuits. Franks A. J., Ironside J. W., Mindham R. H. S., Smith R. J., Spokes E. G. S., Winlow W. Function and Dysfunction of the Basal Ganglia. 1990;1-30 Manchester Univ. Press, Manchester.
38. DeJong J. D., Melvill-Jones G. Akinesia, Hypokinesia, and bradykinesia in the occulomotor system of patients with Parkinson's disease. Exp. Neurol. 32:1971;58-68.
39. Brooks B. A., Fucjs A. F., Finocchio D. Saccadic eye movement deficits in the MPTP monkey model of Parkinson's disease. Brain Res. 383:1986;402-407.
40. Hotsen J. R., Langston E. B., Langston J. W. Saccadic responses to dopamine in human MPTP-induced parkinsonism. Ann. Neurol. 20:1986;456-463.
41. Schultz W., Romo R., Scarnati E., Sundoström E., Jonsson G., Studer A. Saccadic reaction times, eye-arm coordination and spontaneous eye movements in normal and MPTP-treated monkeys. Exp. Brain Res. 78:1989;253-267.
42. Hikosaka O., Wurtz R. H. Visual and oculomotor functions of monkey substantia nigra pars reticulata. I. Relation of substantia nigra to superior colliculus. J. Neurophysiol. 49:1983;1285-1301.
43. Hikosaka O., Sakamoto M., Usui S. Functional properties of monkey caudate neurons. I. Activities related to saccadic eye movements. J. Neurophysiol. 61:1989;780-798.
44. Hikosaka O., Sakamoto M., Usui S. Functional properties of monkey caudate neurons. II. Visual and auditory responses. J. Neurophysiol. 61:1989;799-813.
45. Wurtz R. H., Hikisaka O. The role of the basal ganglia in the initiation of saccadic eye movements. Freund H. J., Beuttner U., Cohen B., Noth J. The Oculomotor and Skeletalmotor System: Differences and Similarities. 1986;175-190 Elsevier, Amsterdam/New York/Oxford.
46. Taylor J. R., Elsworth J. D., Roth R. H., Collier T. J., Sladek J. R. Jr., Redmond D. E. Jr. Improvements in MPTP-induced object retrieval deficits and behavioral deficits after fetal nigral grafting in monkeys. Prog. Brain Res. 82:1990;543-559.
47. Taylor J. R., Elsworth J. D., Roth R. H., Sladek J. R. Jr., Redmond D. E. Jr. Cognitive and motor deficits in the acquisition of an object retrieval/detour task in MPTP-treated monkeys. Brain. 113:1990;617-637.
48. Taylor J. R., Roth R. H., Sladek J. R. Jr., Redmond D. E. Jr. Cognitive and motor deficits in the performance of an object retrieval task with a barrier/detour in monkeys (Cercopithecus aethiops sabaeus) treated with MPTP: Long-term performance and effect of transparency of the barrier. Behav. Neurosci. 104:1990;564-576.
49. Kori A., Miyashita N., Kato M., Hikosaka O., Sadanari U., Matsumura M. Eye movements in monkeys with local dopaminergic depletion in the caudate nucleus. II. Deficits in voluntary saccades. J. Neurosci. 15:1995;928-941.
50. Kato M., Miyashita N., Hikosaka O., Matsumura M., Sadanari U., Kori A. Eye movements in monkeys with local dopaminergic depletion in the caudate nucleus. I. Deficits in spontaneous saccades. J. Neurosci. 15:1995;912-927.
51. Bruce C. J., Goldberg M. E. Primate frontal eye fields. I. Single neuron discharging before saccades. J. Neurophysiol. 53:1985;603-635.
52. Guitton D., Buchel H. A., Douglas R. M. Frontal lobe lesions in man cause difficulties in suppressing reflective glances and in generating goal-directed saccades. Exp. Brain Res. 548:1985;455-472.